An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cardiovascular Systems, Inc. (CSII) will release its operating results for the quarter ending March 31, 2022, on May 4, 2022, before market opening. A conference call to discuss these results is scheduled for 8:00 a.m. CT (9:00 a.m. ET) on the same day. The company specializes in medical devices aimed at treating vascular and coronary diseases, particularly through its advanced orbital atherectomy system, which targets calcified and fibrotic plaque.
Positive
None.
Negative
None.
ST. PAUL, Minn.--(BUSINESS WIRE)--
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) plans to announce its operating results for the quarter ended March 31, 2022 before the market opens on Wednesday, May 4, 2022, and will host a conference call at 8:00 a.m. CT (9:00 a.m. ET) that day to discuss those results.
To access the live webcast, please register for the webcast here. A webcast replay will be available later the same day.
To participate in the conference call, please register for the conference call here.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For more information, visit www.csi360.com and follow us on LinkedIn and Twitter.